Biomea Fusion BMEA
NASDAQ BMEA
$0.59 +0.04 (+7.92%)
As of: Nov 11, 2026 · 11:31 AM EST

Biomea Fusion (BMEA) Price to Sales (2024 - 2026)

Updated

Analysis

Biomea Fusion (BMEA) Price to Sales (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Biomea Fusion 39.97 Mn -121.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 60.83
Jun 30, 2026 57.66
Mar 31, 2026 60.18
Dec 31, 2025 34.86
Sep 30, 2025 58.44
Jun 30, 2025 26.28
Mar 31, 2025 19.54
Dec 31, 2024 24.96
API Access

Biomea Fusion Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=BMEA&period=max&api_key=YOUR_API_KEY